Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 2,857 shares at $13.34 ($39K) on 2019-12-06, disclosed to the SEC on 2019-12-06.
Scheduled sale ($39k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.74 | 2,057 | $28K | 72.6% |
| 2 | $13.34 | 800 | $11K | 27.4% |
| Total | $13.63 avg | 2,857 | $39K | 100% |
| Filing → |
| OPNT | SELL | 2023-01-05 | $29K | — | Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |